scholarly journals May Measurement Month 2019: an analysis of blood pressure screening results from Zambia

2021 ◽  
Vol 23 (Supplement_B) ◽  
pp. B158-B160
Author(s):  
Fastone Goma ◽  
Charity Syatalimi ◽  
Penias Tembo ◽  
Musawa Mukupa ◽  
Theresa Chikopela ◽  
...  
Keyword(s):  
Public Health ◽  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Blood Pressure ◽  
Public Health Policy ◽  
Antihypertensive Medication ◽  
Population Level ◽  
Multiple Imputations ◽  
The Individual ◽  
Treatable Condition

Abstract In Zambia, hypertension accounts for the highest proportion of deaths due to cardiovascular diseases causing 3.3% of all deaths, killing an average of 670 people per year. May Measurement Month (MMM) is an annual global screening campaign aiming to improve awareness of blood pressure (BP) at the individual and population level. Adults (≥18 years) recruited through opportunistic sampling were screened at multiple sites within Lusaka during May and June 2019. Ideally, three BP readings were measured for each participant, and data on lifestyle factors and comorbidities were collected. Data were analysed centrally by the MMM project team and multiple imputations were performed where necessary. Of the total of 9232 enrolled, 8.7% of them had never had their BP measured, 2.5% had diabetes mellitus, 1.9% had had a myocardial infarction, 1.5% had had a stroke, 10.6% were current smokers, and 10.0% consumed alcohol once or more per week. Blood pressure fell from a mean of 128.6/82.9 mmHg for the 1st reading to a mean of 123.2/80.0 mmHg for the 3rd reading. The lowest proportion of participants with hypertension was identified by the 3rd reading alone (30.0%). Of all the participants, 30.7% had hypertension, though only 42.6% of them were aware of their diagnosis. Seven hundred and eighty-three (27.6%) were on antihypertensive medication though only 35.0% of them had controlled BP (systolic BP <140 mmHg and diastolic BP <90 mmHg). Compared with MMM17 data, there is deterioration of the monitored parameters calling for urgent and accelerated public health policy and clinical practice interventions. We think that the MMM campaign should continue annually to raise awareness of this treatable condition.

scholarly journals May Measurement Month 2019: an analysis of blood pressure screening results from Mexico

2021 ◽  
Vol 23 (Supplement_B) ◽  
pp. B104-B106
Author(s):  
Luis Alcocer ◽  
Martin Rosas ◽  
Alfredo Estrada ◽  
Edith Ruiz-Gastelum ◽  
Ernesto J Pombo ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Blood Pressure ◽  
Body Mass Index ◽  
Standard Deviation ◽  
Antihypertensive Medication ◽  
Previous Pregnancy ◽  
Multiple Imputations ◽  
The Past ◽  
The Individual ◽  
Mixed Ethnicity

Abstract May Measurement Month 2019 (MMM19) in Mexico was an opportunistic survey, aimed to improve blood pressure (BP) awareness at the individual and population levels. This survey followed the methodology of MMM19, previously published. The total number of participants screened was 39 700, 56.7% female, 36.6% were of mixed ethnicity, mean age [standard deviation (SD)] was 46.9 (17.4) years, and mean body mass index was 27.2 (SD: 4.4) kg/m2. Seven per cent of the participants reported having diabetes, 2.4% reported having a myocardial infarction in the past, 1.1% stroke, 2.0% were pregnant at the time of the survey, 3.7% of women had suffered from hypertension in a previous pregnancy, 11.4% declared that they were smokers, and 47.0% drank alcohol at least once a week. After multiple imputations, of all 39 700 participants, 10 140 (25.5%) had hypertension; of all participants with hypertension, 43.8% were aware of their diagnosis, 41.7% were on antihypertensive medication, and 27.8% had controlled BP (systolic BP <140 mmHg and diastolic BP <90 mmHg). Of those on antihypertensive medication, 27.8% had controlled BP. In Mexico, MMM is the largest hypertension survey ever done, it provides complementary data to the existing information on arterial hypertension in the country and helps to increase the visibility of hypertension: a priority health problem.

scholarly journals May Measurement Month 2019

Hypertension ◽  
2020 ◽  
Vol 76 (2) ◽  
pp. 333-341 ◽  
Author(s):  
Thomas Beaney ◽  
Aletta E. Schutte ◽  
George S. Stergiou ◽  
Claudio Borghi ◽  
Dylan Burger ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Antihypertensive Medication ◽  
Blood Pressure Measurement ◽  
Population Level ◽  
Mixed Effects ◽  
Mixed Effects Models ◽  
Pressure Data ◽  
Single Drug ◽  
Blood Pressure Data ◽  
The Individual

Elevated blood pressure remains the single biggest risk factor contributing to the global burden of disease and mortality. May Measurement Month is an annual global screening campaign aiming to improve awareness of blood pressure at the individual and population level. Adults (≥18 years) recruited through opportunistic sampling were screened at sites in 92 countries during May 2019. Ideally, 3 blood pressure readings were measured for each participant, and data on lifestyle factors and comorbidities were collected. Hypertension was defined as a systolic blood pressure ≥140 mm Hg, or a diastolic blood pressure ≥90 mm Hg (mean of the second and third readings) or taking antihypertensive medication. When necessary, multiple imputation was used to estimate participants’ mean blood pressure. Mixed-effects models were used to evaluate associations between blood pressure and participant characteristics. Of 1 508 130 screenees 482 273 (32.0%) had never had a blood pressure measurement before and 513 337 (34.0%) had hypertension, of whom 58.7% were aware, and 54.7% were on antihypertensive medication. Of those on medication, 57.8% were controlled to <140/90 mm Hg, and 28.9% to <130/80 mm Hg. Of all those with hypertension, 31.7% were controlled to <140/90 mm Hg, and 350 825 (23.3%) participants had untreated or inadequately treated hypertension. Of those taking antihypertensive medication, half were taking only a single drug, and 25% reported using aspirin inappropriately. This survey is the largest ever synchronized and standardized contemporary compilation of global blood pressure data. This campaign is needed as a temporary substitute for systematic blood pressure screening in many countries worldwide.

scholarly journals Characteristics of Acute Myocardial Infarction Patients

2020 ◽  
Vol 9 (2) ◽  
pp. 1017-1026
Author(s):  
Desi Natalia Trijayanti Idris ◽  
Dian Taviyanda ◽  
Srinalesti Mahanani
Keyword(s):  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Blood Pressure ◽  
Acute Myocardial Infarction ◽  
Family History ◽  
Frequency Distribution ◽  
Pulse Frequency ◽  
Education History ◽  
Male And Female ◽  
History Of

Acute myocardial infarction (AMI) is a disease that has a high mortality. Usually happens to anyone and regardless of age, both male and female. The purpose of this study was to describe the characteristics of acute myocardial infarction patients hospitalized. This study uses a descriptive design. The variables used in this study were the characteristics of acute myocardial infarction patients consisting of gender, age, education, history of hypertension, history of diabetes mellitus, family history of acute myocardial infarction, blood pressure and pulse frequency. The number of samples used was 35 respondents who analyzed the data using a frequency distribution. The results showed that the characteristics of 35 respondents showed that the majority of AMI patients occurred in men, namely 60%, the majority were aged 56-60, namely 34.3%, the majority had a history of hypertension, diabetes mellitus and also a family history of having AMI. 

scholarly journals Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication

Hypertension ◽  
2016 ◽  
Vol 68 (6) ◽  
pp. 1355-1364 ◽  
Author(s):  
Giuseppe Mancia ◽  
Christopher P. Cannon ◽  
Ilkka Tikkanen ◽  
Cordula Zeller ◽  
Ludwin Ley ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Antihypertensive Medication

scholarly journals Smart Sanitation—Biosensors as a Public Health Tool in Sanitation Infrastructure

2020 ◽  
Vol 17 (14) ◽  
pp. 5146 ◽  
Author(s):  
Emma Rary ◽  
Sarah M. Anderson ◽  
Brandon D. Philbrick ◽  
Tanvi Suresh ◽  
Jasmine Burton
Keyword(s):  
Public Health ◽  
Health Monitoring ◽  
Disease Surveillance ◽  
Population Level ◽  
Cost Effective ◽  
Small Scale ◽  
Individual Level ◽  
Emergent Technologies ◽  
The Individual ◽  
Sanitation Infrastructure

The health of individuals and communities is more interconnected than ever, and emergent technologies have the potential to improve public health monitoring at both the community and individual level. A systematic literature review of peer-reviewed and gray literature from 2000-present was conducted on the use of biosensors in sanitation infrastructure (such as toilets, sewage pipes and septic tanks) to assess individual and population health. 21 relevant papers were identified using PubMed, Embase, Global Health, CDC Stacks and NexisUni databases and a reflexive thematic analysis was conducted. Biosensors are being developed for a range of uses including monitoring illicit drug usage in communities, screening for viruses and diagnosing conditions such as diabetes. Most studies were nonrandomized, small-scale pilot or lab studies. Of the sanitation-related biosensors found in the literature, 11 gathered population-level data, seven provided real-time continuous data and 14 were noted to be more cost-effective than traditional surveillance methods. The most commonly discussed strength of these technologies was their ability to conduct rapid, on-site analysis. The findings demonstrate the potential of this emerging technology and the concept of Smart Sanitation to enhance health monitoring at the individual level (for diagnostics) as well as at the community level (for disease surveillance).

scholarly journals Analyzing 24-Hour Blood Pressure Measurements with a Novel Cuffless Pulse Transit Time Device in Clinical Practice—Does the Software for Heartbeat Detection Matter?

Diagnostics ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 361
Author(s):  
Leo Kilian ◽  
Philipp Krisai ◽  
Thenral Socrates ◽  
Christian Arranto ◽  
Otmar Pfister ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Transit Time ◽  
Pulse Transit Time ◽  
Population Level ◽  
Raw Data ◽  
Invasive Blood Pressure ◽  
Individual Level ◽  
Non Invasive ◽  
The Individual ◽  
The Impact

Background: The Somnotouch-Non-Invasive-Blood-Pressure (NIBP) device delivers raw data consisting of electrocardiography and photoplethysmography for estimating blood pressure (BP) over 24 h using pulse-transit-time. The study’s aim was to analyze the impact on 24-hour BP results when processing raw data by two different software solutions delivered with the device. Methods: We used data from 234 participants. The Somnotouch-NIBP measurements were analyzed using the Domino-light and Schiller software and compared. BP values differing >5 mmHg were regarded as relevant and explored for their impact on BP classification (normotension vs. hypertension). Results: Mean (±standard deviation) absolute systolic/diastolic differences for 24-hour mean BP were 1.5 (±1.7)/1.1 (±1.3) mm Hg. Besides awake systolic BP (p = 0.022), there were no statistically significant differences in systolic/diastolic 24-hour mean, awake, and asleep BP. Twenty four-hour mean BP agreement (number (%)) between the software solutions within 5, 10, and 15 mmHg were 222 (94.8%), 231 (98.7%), 234 (100%) for systolic and 228 (97.4%), 232 (99.1%), 233 (99.5%) for diastolic measurements, respectively. A BP difference of >5 mmHg was present in 24 (10.3%) participants leading to discordant classification in 4–17%. Conclusion: By comparing the two software solutions, differences in BP are negligible at the population level. However, at the individual level there are, in a minority of cases, differences that lead to different BP classifications, which can influence the therapeutic decision.

Sleep and pain

2018 ◽  
Author(s):  
Nicole K. Y. Tang ◽  
Esther F. Afolalu ◽  
Fatanah Ramlee
Keyword(s):  
Public Health ◽  
Primary Care ◽  
Population Level ◽  
Population Based ◽  
Future Research ◽  
Long Term Conditions ◽  
Treatment Development ◽  
The Individual ◽  
The Relationship

Pain and sleeplessness are two of the commonest reasons for primary care appointments. The prevalence of each problem alone is high, and to add to the complexity, pain and insomnia frequently co-occur, with pain interrupting sleep and pain being further aggravated following a poor night’s sleep. Sleep and pain management are increasingly recognized as important to public health. In particular, insomnia and chronic pain are long-term conditions that actively contribute to morbidity, disability, economic burden to society, and suffering to the individual and immediate family. This chapter examines the interrelationship between the two at the population level. Specifically, evidence from population-based studies regarding the co-occurrence and temporal link of pain and sleep is reviewed, with moderators and mediators of the relationship highlighted. Possible directions for future research and treatment development are also outlined.

scholarly journals Diabetes in India: Measuring the dynamics of a public health catastrophe

2016 ◽  
Vol 04 (02) ◽  
pp. 077-084 ◽  
Author(s):  
Pranav Patnaik ◽  
Kamlesh Jain ◽  
P. Chandra ◽  
Jaya Pathak ◽  
K. Raman ◽  
...  
Keyword(s):  
Public Health ◽  
Health Care ◽  
Health Policy ◽  
Public Health Policy ◽  
Lifestyle Changes ◽  
Management Policy ◽  
Urban Migration ◽  
Different Populations ◽  
The Individual ◽  
The Impact

AbstractDiabetes has emerged as a major concern in the Indian health-care setting but has been underrecognized as a significant challenge in the context of public health policy due to the necessity to handle acute health conditions. Trends obtained from national and regional surveys over time strongly point to the increasing diabetes burden. In addition, people with undiagnosed and prediabetes can aggravate the burden in the near future. Long-term concerns arise from the rapid transformations such as urbanization, rural–urban migration, and lifestyle changes happening across different populations of India. Attempts at creating a rational diabetes prevention and management policy are severely hindered by a lack of comprehensive, standardized data on diabetes prevalence, and trends in the evolution of the epidemic. The impact of diabetes is multifaceted, ranging from the clinical impact of higher secondary complications to personal, psychosocial, and financial effects on the individual which create a cycle of negative outcomes. Given the chronic nature of diabetes, the impact is likely to remain as a self-perpetuating burden on the health-care system. The magnitude, spread, and impact of the diabetes epidemic are substantial, and it has transitioned to being a pandemic with potentially catastrophic implications for the Indian Public Health System. It is therefore essential to create public health policy specific to diabetes care that is effective in reducing the multidimensional impact of diabetes catastrophe and prevent further multiplication of this pandemic.

scholarly journals May Measurement Month 2018: an analysis of blood pressure screening results from Oman

2020 ◽  
Vol 22 (Supplement_H) ◽  
pp. H100-H103
Author(s):  
Sunil K Nadar ◽  
Hassan Al-Riyami ◽  
Adil Al-Riyami ◽  
Hatim Al-Lawati ◽  
Benny Panakkal ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Antihypertensive Medication ◽  
Public Awareness ◽  
Shopping Malls ◽  
Cross Sectional ◽  
Multiple Imputations ◽  
Previous Diagnosis ◽  
Undiagnosed Hypertension ◽  
Public Areas ◽  
Set Up

Abstract As per WHO estimates, around 17% of the adult Omani population are hypertensive. However, people with hypertension are often unaware of the diagnosis, and so the May Measurement Month (MMM) programme was set up to raise awareness of the importance of blood pressure (BP) screening. A cross-sectional screening of BP of subjects aged 18 years or more was carried out in May 2018 at various sites in Muscat, Oman. Screening sites were set up at the reception areas of participating hospitals, and at a few public areas such as shopping malls and workplaces of the volunteers. Blood pressure was measured according to a standardized protocol, and hypertension was defined as per the 2018 European Society of Hypertension guidelines. The data were analysed centrally by the MMM project team. A total of 12 689 individuals (mean age 40.6 ± 12.5 years, 72% male) were screened. The crude mean BP of the second and third readings (where three readings were taken, n = 4 738) was 127.1/79.2 mmHg. After multiple imputations, the average age and sex standardized BP was 127.3/80.2 mmHg. Of all participants, 29.8% had hypertension. There were 1 983 patients with a previous diagnosis of hypertension, of whom 1 810 were on antihypertensive medication. A further 1 973 subjects were newly diagnosed with hypertension. Of those on antihypertensive medication, 34.9% had uncontrolled BP readings. Screening programmes such as MMM are useful to identify persons with undiagnosed hypertension. However, more educational activities are required to increase the public awareness regarding the dangers of hypertension.

Sign in / Sign up

Export Citation Format

Share Document